The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival
Abstract
Cervical squamous cell carcinomas are composed histologically of tumour cell islands surrounded by varying amounts of tumour stroma, the amount and composition of which are influenced by local TGF‐β 1. TGF‐β 1 is secreted in an inactive complex with latency‐associated peptide (LAP). Both LAP and the extracellular matrix (ECM) protein fibronectin are important ligands for the integrin receptor αvβ6. While αvβ6 is only weakly expressed by normal epithelia, it is up‐regulated in different carcinomas where it generally reflects a more aggressive phenotype. In cervical cancer, the expression of αvβ6 has not thus far been investigated. Given the ability of αvβ6 both to activate TGF‐β 1 and to interact with fibronectin, we studied correlations between the expression of these components and disease parameters in a large cohort of cervical cancer specimens. We analysed αvβ6 expression using immunohistochemistry in primary cervical squamous carcinomas of FIGO stage IA to IIB patients and correlated the findings with formerly investigated fibronectin and TGF‐β 1 expression and clinico‐pathological parameters. αvβ6 expression was also examined in cervical intra‐epithelial neoplasia (CIN) and lymph node metastases. αvβ6 was only weakly expressed in normal epithelium but clearly up‐regulated in CIN lesions. In carcinomas, strong expression of αvβ6 in tumour cells correlated with different clinico‐pathological parameters and with worse overall and disease‐free survival. Furthermore, αvβ6 expression correlated positively with TGF‐β 1 mRNA expression as well as with fibronectin expression. Overexpression of αvβ6 in cervical squamous carcinomas is an unfavourable prognostic factor. This might reflect an increased capacity of αvβ6‐expressing tumour cells to migrate in a fibronectin‐rich ECM and/or to activate TGF‐β 1 at the tumour/stroma interface, both of which processes may contribute to cervical cancer progression. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“Invasive cervical carcinomas are characteristically composed of infiltrating epithelial tumour cell nests surrounded by widely varying amounts of specialized tumour stroma, which is indispensable for tumour growth [3,4].”
BackgroundA cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Cited by
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Berrier, A. L., & Yamada, K. M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21237 · Cited by 957
Derailed endocytosis: an emerging feature of cancer
Mosesson, Y., Mills, G. B., & Yarden, Y. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2521 · Cited by 718
Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing
Margadant, C., & Sonnenberg, A. (2010) · The EMBO Reports · doi:10.1038/embor.2009.276 · Cited by 653
Metadata
- Authors
- Hazelbag, S., Kenter, G., Gorter, A., Dreef, E., Koopman, L., Violette, S., Weinreb, P., & Fleuren, G.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2007-05-14
- Volume
- 212
- Issue
- 3
- Pages
- 316-324
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2044570850
- Cited by
- 178
- References
- 2
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.